Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - risperidone 1mg;   - film coated tablet - 1 mg - active: risperidone 1mg   excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc   sodium laurilsulfate - treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness),and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - risperidone - oral tablet - 1mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - risperidone - oral tablet - 1mg

Spojené státy - angličtina - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 2 mg - risperidone tablets are indicated for the treatment of schizophrenia. efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see clinical studies (14.1)] . monotherapy risperidone tablets are indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see clinical studies (14.2)] .  adjunctive therapy risperidone tablets adjunctive therapy with lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in one short-term trial in adults [see clinical studies (14.3)] . risperidone tablets are indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate self-injuriousness,

Kanada - angličtina - Health Canada

pharmascience inc - risperidone - tablet (orally disintegrating) - 1mg - risperidone 1mg - atypical antipsychotics

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - risperidone 1mg - film coated tablet - 1 mg - active: risperidone 1mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose opadry white oy-58900 purified talc sodium laurilsulfate starch - risperidone tablets are indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. · risperidone tablets also alleviate affective symptoms (such as depression, guiltfeelings, anxiety) associated with schizophrenia.

Kanada - angličtina - Health Canada

pharmel inc - risperidone - tablet (orally disintegrating) - 1mg - risperidone 1mg - atypical antipsychotics

Kanada - angličtina - Health Canada

dominion pharmacal - risperidone - tablet (orally disintegrating) - 1mg - risperidone 1mg - atypical antipsychotics

Kanada - angličtina - Health Canada

nu-pharm inc - risperidone - tablet - 1mg - risperidone 1mg - atypical antipsychotics

Kanada - angličtina - Health Canada

mylan pharmaceuticals ulc - risperidone - tablet - 1mg - risperidone 1mg - atypical antipsychotics